A real-world analysis conducted on a large ophthalmology registry confirmed that best results with anti-VEGF injections in age-related macular degeneration are obtained in patients who initiate treatment when visual acuity is still good.
Unfortunately, these patients are a minority, and there are too many cases in which the onset of neovascular exudation is not detected promptly.
“Only 34.3% of eyes had 20/40 or better at baseline, and those were the eyes that maintained a mean VA of 20/40 or better in the long term with anti-VEGF treatment,” study co-author Allen (Read more...)
Uncategorized